GTR 96727818
Bids Are Invited For Acquisition Of The Drug Lanadelumab 150 Mg/Ml Injectable Solution.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
96727818
Tendering Authority
Subscribe to view
Tender No
117/25/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of The Drug Lanadelumab 150 Mg/Ml Injectable Solution.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
29-05-2025
Closed
Work Detail
Pharmacological Group: Monoclonal Antibody, Active Principle: Lanadelumab, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 150, Unit: Mg / Ml, Volume: 2 Ml, Presentation: Flask, Accessory: Infusion Set, Form Supply: Unit
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
da92ef5b-f073-4d88-90e5-37c346549c32.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.